510(k) K111268

CONTOUR (R) NEXT BLOOD GLUCOSE MONITORING SYSTEM by Bayer Healthcare — Product Code LFR

K111268 is an FDA 510(k) premarket notification submitted by Bayer Healthcare for the device "CONTOUR (R) NEXT BLOOD GLUCOSE MONITORING SYSTEM". The FDA issued a decision of Substantially Equivalent on March 6, 2012. The device falls under product code LFR (Glucose Dehydrogenase, Glucose), a Class II device regulated under 21 CFR 862.1345. Bayer Healthcare has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 6, 2012
Date Received
May 4, 2011
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Glucose Dehydrogenase, Glucose
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type